Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Organon and Co
With
Institute for Applied Economics and Health Research Aps
Age
35–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Participant's study medical information available in population-based health and medical registries, prescription registries, and mortality registries in Denmark, Finland, Norway, or Sweden within the observation period of 1995 to 2013
Male with breast cancer with medical information in one of the 4 country-specific registries in this study OR country- and age-matched control men without breast cancer and with medical information in one of the 4 country-specific registries
Study participant's exposure to finasteride is available
You may not be if
For country- and age-matched control men without breast cancer
Previous cancer diagnosis or treatment for cancer except non-melanoma skin cancer
Previous prostatectomy
Finasteride or dutasteride use (dutasteride is a drug in the same class as finasteride) within first 6 months of registration in the prescription registers (new user design).
Clareo Health | Finasteride (MK-0906) and Male Breast Cancer - A Register-Based Nested Case-Control Study (MK-0906-162/2003.021).
